S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
Log in

Bruker Stock Forecast, Price & News

-0.74 (-1.22 %)
(As of 01/25/2021 12:00 AM ET)
Today's Range
Now: $60.10
50-Day Range
MA: $56.29
52-Week Range
Now: $60.10
Volume404,042 shs
Average Volume507,130 shs
Market Capitalization$9.20 billion
P/E Ratio58.92
Dividend Yield0.26%
Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies; and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, defect-detection equipment for semiconductor process control, and spark optical emission spectroscopy systems, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology, and diagnostics companies; chemical, food and beverage, clinical, and polymer companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, environmental and clinical microbiology laboratories, and hospitals and government departments and agencies, as well as agriculture, and food and beverage safety companies; nanotechnology, semiconductor, and industrial companies; and raw material manufacturers and other businesses through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation has collaboration with Inscopix. Bruker Corporation was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Bruker logo


Overall MarketRank

1.88 out of 5 stars

Computer And Technology Sector

110th out of 1,501 stocks

Analytical Instruments Industry

2nd out of 29 stocks

Analyst Opinion: 1.2Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
Current SymbolNASDAQ:BRKR
Phone(978) 663-3660
Year FoundedN/A



Sales & Book Value

Annual Sales$2.07 billion
Cash Flow$2.12 per share
Book Value$5.96 per share


Net Income$197.20 million


Market Cap$9.20 billion
Next Earnings Date3/26/2021 (Estimated)
-0.74 (-1.22 %)
(As of 01/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for BRKR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Bruker (NASDAQ:BRKR) Frequently Asked Questions

How has Bruker's stock price been impacted by COVID-19 (Coronavirus)?

Bruker's stock was trading at $40.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BRKR stock has increased by 50.3% and is now trading at $60.10.
View which stocks have been most impacted by COVID-19

Is Bruker a buy right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Bruker stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BRKR, but not buy additional shares or sell existing shares.
View analyst ratings for Bruker
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Bruker?

Wall Street analysts have given Bruker a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Bruker wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Frank H. Laukien's approval rating as Bruker's CEO?

75 employees have rated Bruker CEO Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among Bruker's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is Bruker's next earnings date?

Bruker is scheduled to release its next quarterly earnings announcement on Friday, March 26th 2021.
View our earnings forecast for Bruker

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) posted its earnings results on Saturday, November, 7th. The medical research company reported $0.42 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.31 by $0.11. The medical research company earned $511.40 million during the quarter, compared to analyst estimates of $485.25 million. Bruker had a trailing twelve-month return on equity of 21.78% and a net margin of 8.04%. The firm's revenue was down 1.9% on a year-over-year basis. During the same quarter last year, the company earned $0.43 EPS.
View Bruker's earnings history

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker declared a quarterly dividend on Friday, November 13th. Shareholders of record on Tuesday, December 1st will be paid a dividend of $0.04 per share on Friday, December 18th. This represents a $0.16 annualized dividend and a yield of 0.27%. The ex-dividend date of this dividend is Monday, November 30th.
View Bruker's dividend history

Is Bruker a good dividend stock?

Bruker pays an annual dividend of $0.16 per share and currently has a dividend yield of 0.26%. The dividend payout ratio of Bruker is 10.19%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Bruker will have a dividend payout ratio of 9.30% next year. This indicates that Bruker will be able to sustain or increase its dividend.
View Bruker's dividend history.

What guidance has Bruker issued on next quarter's earnings?

Bruker issued an update on its fourth quarter 2020 After-Hours earnings guidance on Monday, January, 11th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $620-625 million, compared to the consensus revenue estimate of $586.94 million.

What price target have analysts set for BRKR?

11 Wall Street analysts have issued 12 month target prices for Bruker's stock. Their forecasts range from $27.00 to $64.00. On average, they expect Bruker's share price to reach $48.39 in the next twelve months. This suggests that the stock has a possible downside of 19.5%.
View analysts' price targets for Bruker
or view Wall Street analyst' top-rated stocks.

Are investors shorting Bruker?

Bruker saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 1,750,000 shares, a decline of 28.9% from the December 15th total of 2,460,000 shares. Based on an average daily trading volume, of 541,300 shares, the days-to-cover ratio is currently 3.2 days. Approximately 1.7% of the company's shares are short sold.
View Bruker's Short Interest

Who are some of Bruker's key competitors?

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), The Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

Who are Bruker's key executives?

Bruker's management team includes the following people:
  • Dr. Frank H. Laukien, Chairman, CEO & Pres (Age 61, Pay $1.5M)
  • Mr. Gerald N. Herman, CFO, VP & Corp. Controller (Age 63, Pay $700.32k)
  • Dr. Mark R. Munch, Exec. VP and Pres of Bruker Nano Group & Bruker Nano Surfaces Division (Age 59, Pay $735.04k)
  • Mr. Juergen Srega, Pres of Bruker CALID Group & Bruker Daltonics Division (Age 66, Pay $700.31k)
  • Dr. Falko Busse Ph.D., Pres of Bruker BioSpin Group (Age 54, Pay $585.64k)
  • Ms. Miroslava Atanassova Minkova, Director of Investor Relations & Corp. Devel.
  • Mr. Collin J. D'Silva, Pres of Chemical Analysis Division (Age 64)
  • Stacey Desrochers, Treasurer & Director of Investor Relations
  • Mr. Urban Faeh, Pres of Bruker Optics Division & Managing Director of Bruker Optik GmbH
  • Dr. Burkhard Prause, Pres and CEO of Bruker Energy & Supercon Technologies, Inc. (Age 54)

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Who are Bruker's major shareholders?

Bruker's stock is owned by a variety of institutional and retail investors. Top institutional investors include Boston Trust Walden Corp (0.51%), Scout Investments Inc. (0.15%), Candriam Luxembourg S.C.A. (0.04%), Strs Ohio (0.01%), BLB&B Advisors LLC (0.01%) and Nisa Investment Advisors LLC (0.01%). Company insiders that own Bruker stock include Burkhard Prause, Cynthia M Friend, Frank H Laukien, Marc A Kastner and Mark Munch.
View institutional ownership trends for Bruker

Which institutional investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including Strs Ohio, and BLB&B Advisors LLC. Company insiders that have sold Bruker company stock in the last year include Cynthia M Friend, and Marc A Kastner.
View insider buying and selling activity for Bruker
or view top insider-selling stocks.

Which institutional investors are buying Bruker stock?

BRKR stock was acquired by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, Candriam Luxembourg S.C.A., Scout Investments Inc., Forte Capital LLC ADV, IBM Retirement Fund, Nisa Investment Advisors LLC, Exchange Traded Concepts LLC, and Global Retirement Partners LLC.
View insider buying and selling activity for Bruker
or or view top insider-buying stocks.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $60.10.

How big of a company is Bruker?

Bruker has a market capitalization of $9.20 billion and generates $2.07 billion in revenue each year. The medical research company earns $197.20 million in net income (profit) each year or $1.57 on an earnings per share basis. Bruker employs 7,230 workers across the globe.

What is Bruker's official website?

The official website for Bruker is www.bruker.com.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at (978) 663-3660 or via email at [email protected]

This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.